5-Day Preoperative Radiation for Soft Tissue Sarcoma

Recruiting

I'm Interested

Trial ID: NCT06087861

Purpose

The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk or retroperitoneum. This is in contrast to standard preoperative radiation, which is given over 25 days.

Official Title

Phase 2 5-Day Preoperative Radiation for Soft Tissue Sarcoma

Stanford Investigator(s)

Everett J. Moding, MD, PhD
Everett J. Moding, MD, PhD

Assistant Professor of Radiation Oncology (Radiation Therapy)

Eligibility


Inclusion Criteria:

   1. Histologically confirmed soft tissue sarcoma of the extremity, trunk or
   retroperitoneum.

   2. Has been offered preoperative radiation and surgery as part of standard-of-care
   treatment

   3. Age ≥ 18

   4. KPS ≥ 70 or ECOG 0 to 2

   5. Life expectancy ≥ 6 months

   6. If a woman is of childbearing potential, a negative serum or urine pregnancy test must
   be documented.

   7. Ability to understand and the willingness to personally sign the written IRB approved
   informed consent document.

Exclusion Criteria:

   1. History of prior radiation to the area to be treated.

   2. Active use of other anti-cancer investigational agents.

   3. Planned use of concurrent chemotherapy, targeted therapy, or immunotherapy with
   radiation therapy (defined as the time interval starting 1 week before the first and
   last fraction of radiation therapy and surgery).

   4. Pregnancy.

Intervention(s):

radiation: External Beam Radiotherapy

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jillian Skerchak
650-721-4072

New Trial Alerts